Module 27 · Toxicology & envenomation

Poisoning approach and drug overdoses

NewPhase 2

Poisoning in the ICU: initial approach and toxidromes, decontamination and enhanced elimination (AACT/EXTRIP), paracetamol, cardiotoxic overdoses (TCA, CCB, beta-blocker, digoxin), toxic alcohols, and an antidote reference with Indian availability notes.

6 topics

Drugs in this module

Doses written for this module's context. The same drug may read differently in another module.

Naloxone

Opioid antagonist

Indications
Opioid toxicity with respiratory depression
Adult dose
0.04-0.4 mg IV, repeat every 2-3 min to adequate breathing (up to 10 mg); infusion two-thirds of the effective reversal dose per hour.
Preparation (India)
0.4 mg/mL ampoules.
Cautions
Precipitated withdrawal and pulmonary oedema with large doses; shorter half-life than many opioids.

Activated charcoal

Adsorbent

Indications
Recent ingestion (usually < 1-2 h) of a toxic amount of an adsorbable drug, airway protected
Adult dose
Single dose 50 g (1 g/kg) orally/NG. Multiple-dose (carbamazepine, dapsone, phenobarbital, quinine, theophylline): 50 g, then 25 g every 4 h (or 12.5 g/h).
Cautions
Aspiration; contraindicated with unprotected airway, ileus/obstruction, corrosives, hydrocarbons. Does not bind alcohols, metals (iron, lithium), acids/alkalis.

N-acetylcysteine

Antidote (glutathione precursor)

Indications
Paracetamol poisoning above nomogram line or with liver injury
Adult dose
Two-bag regimen (ANZ): 200 mg/kg over 4 h, then 100 mg/kg over 16 h. Traditional 3-bag: 150 mg/kg over 1 h, 50 mg/kg over 4 h, 100 mg/kg over 16 h. Continue 100 mg/kg/16 h until criteria met.
Preparation (India)
200 mg/mL; Indian 2 g/10 mL ampoules; dilute in 5% dextrose or NS.
Cautions
Anaphylactoid reactions (fewer with 2-bag/12-h regimens): pause, antihistamine, restart slower.

Sodium bicarbonate 8.4%

Alkalinising agent

Indications
TCA/sodium-channel blocker cardiotoxicity (QRS > 100 ms); salicylate; methanol acidosis
Adult dose
Sodium-channel blockade: 1-2 mEq/kg (mmol/kg) IV bolus, repeat to QRS narrowing, target pH 7.45-7.55. Salicylate: 1-2 mEq/kg bolus then infusion to urine pH 7.5-8.
Preparation (India)
8.4% = 1 mEq/mL; 7.5% (0.9 mEq/mL) in many Indian hospitals.
Cautions
Hypokalaemia, hypernatraemia, volume overload.

Calcium chloride 10% / gluconate 10%

Electrolyte

Indications
CCB poisoning; hyperkalaemia; hypocalcaemia
Adult dose
CCB: calcium chloride 10% 10-20 mL (or gluconate 10% 30-60 mL) IV, repeat every 10-20 min or infusion (chloride 0.2-0.4 mL/kg/h); target ionised Ca up to 2× normal.
Cautions
Chloride via central line (tissue necrosis).

Insulin (high-dose insulin euglycaemic therapy)

Inotrope (metabolic)

Indications
CCB and beta-blocker poisoning with myocardial dysfunction
Adult dose
1 units/kg IV bolus, then 1 units/kg/h, titrate every 10-15 min up to 10 units/kg/h; dextrose 25 g bolus if glucose < 250 mg/dL, then 0.5 g/kg/h; glucose every 15-30 min, potassium hourly.
Preparation (India)
Concentrated infusion e.g. 500 units in 50 mL NS (10 units/mL) to limit volume.
Cautions
Hypoglycaemia (may persist for hours after stopping), hypokalaemia.

Glucagon

Inotrope/chronotrope (cAMP)

Indications
Beta-blocker poisoning (adjunct)
Adult dose
3-10 mg (0.05-0.15 mg/kg) IV over 2-5 min, then 3-5 mg/h infusion.
Cautions
Vomiting (protect airway), hyperglycaemia; expensive and often unavailable in large quantities in India.

Lipid emulsion 20%

Lipid sink

Indications
Local anaesthetic systemic toxicity; refractory lipophilic drug cardiotoxicity (bupivacaine, some CCB, TCA) as rescue
Adult dose
1.5 mL/kg bolus over 1 min, then 0.25 mL/kg/min (repeat bolus once or twice; max ~10-12 mL/kg).
Cautions
Interferes with lab tests, pancreatitis, ARDS; recommended for LAST; only rescue for other drugs.

Digoxin-specific antibody fragments (Fab)

Antidote

Indications
Digoxin toxicity with life-threatening arrhythmia, K > 6 mmol/L, end-organ dysfunction
Adult dose
Acute: 2-5 vials (40 mg each) titrated; empirical 10 vials for cardiac arrest. Chronic: 1-2 vials.

Fomepizole

Alcohol dehydrogenase inhibitor

Indications
Methanol or ethylene glycol poisoning
Adult dose
15 mg/kg IV over 30 min, then 10 mg/kg q12h × 4 doses, then 15 mg/kg q12h; q4h during haemodialysis.

Ethanol (antidote)

Alcohol dehydrogenase competitive substrate

Indications
Methanol/ethylene glycol when fomepizole unavailable
Adult dose
Load 600-800 mg/kg (IV 10% ethanol ~8 mL/kg, or oral 40% spirit ~2 mL/kg diluted); maintenance 80-130 mg/kg/h (higher in drinkers and doubled on haemodialysis); target blood ethanol 100-150 mg/dL.
Cautions
CNS depression, hypoglycaemia, phlebitis; needs ethanol levels every 2-4 h.

Folinic acid (or folic acid)

Cofactor

Indications
Methanol poisoning (formate metabolism)
Adult dose
Folinic acid 1 mg/kg (max 50 mg) IV q4-6h (folic acid 50 mg IV q6h if unavailable).

Octreotide

Somatostatin analogue

Indications
Sulfonylurea-induced recurrent hypoglycaemia
Adult dose
50 mcg SC/IV every 6 h (or 25-50 mcg/h infusion).

Methylene blue

Reducing agent

Indications
Methaemoglobinaemia (> 20-30% or symptomatic)
Adult dose
1-2 mg/kg IV over 5 min; repeat after 1 h if needed.
Cautions
Contraindicated in G6PD deficiency; serotonin syndrome with SSRIs.

Hydroxocobalamin

Cyanide antidote

Indications
Cyanide poisoning (smoke inhalation, nitroprusside, cassava/amygdalin)
Adult dose
5 g IV over 15 min (repeat 5 g if needed).

Pyridoxine

Vitamin B6

Indications
Isoniazid-induced seizures
Adult dose
1 g per g of isoniazid ingested (unknown: 5 g IV over 5-15 min).

Module references (16)

  1. 1

    Farkas J. The Internet Book of Critical Care (IBCC). EMCrit Project; continuously updated.

  2. 2

    Chyka PA, Seger D, Krenzelok EP, Vale JA; AACT/EAPCCT. Position paper: single-dose activated charcoal. Clin Toxicol 2005;43:61-87.

  3. 3

    Benson BE, Hoppu K, Troutman WG, et al. Position paper update: gastric lavage for gastrointestinal decontamination. Clin Toxicol 2013;51:140-6.

  4. 4

    Thanacoody R, Caravati EM, Troutman B, et al. Position paper update: whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol 2015;53:5-12.

  5. 5

    American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 1999;37:731-51.

  6. 6

    Chiew AL, Reith D, Pomerleau A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust 2020;212:175-83.

  7. 7

    Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open 2023;6:e2327739.

  8. 8

    Bateman DN, Dear JW, Thanacoody HKR, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning (SNAP): a randomised controlled trial. Lancet 2014;383:697-704.

  9. 9

    St-Onge M, Anseeuw K, Cantrell FL, et al. Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med 2017;45:e306-15.

  10. 10

    Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol 2011;49:277-83.

  11. 11

    Gosselin S, Hoegberg LCG, Hoffman RS, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol 2016;54:899-923.

  12. 12

    Chan BS, Buckley NA. Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clin Toxicol 2014;52:824-36.

  13. 13

    Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 2002;40:415-46.

  14. 14

    Roberts DM, Yates C, Megarbane B, et al. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Crit Care Med 2015;43:461-72.

  15. 15

    Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol 2015;10:875-87.

  16. 16

    Juurlink DN, Gosselin S, Kielstein JT, et al. Extracorporeal treatment for salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med 2015;66:165-81.